Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bramm

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|January 1, 1980
Basic antiinflammatory compounds. N,N',N''-Trisubstituted guanidinesS Rachlin, E Bramm, I Ahnfelt-Rønne, et al.
Agents and Actions|April 1, 1980
Macrophages from adjuvent arthritic rats preferentially synthetize prostacyclinI Ahnfelt-Rønne, L Binderup, E Bramm, et al.
Calcified Tissue International|February 1, 1991
Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisoloneP Geusens, J Dequeker, J Nijs, et al.
Endocrinology|April 1, 1996
Effect of 1alpha-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat modelJ Aerssens, R van Audekercke, M Talalaj, et al.
Breast Cancer Research and Treatment|September 25, 2003
Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumorsK W Colston, G Pirianov, E Bramm, et al.
Agents and Actions|December 1, 1977
Effect of calcitonin on different inflammatory modelsS E Abdullahi, E A Martelli, E Bramm, et al.
Agents and Actions|September 1, 1976
Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugsE Arrigoni-Martelli, E Bramm, E C Huskisson, et al.
Calcified Tissue International|December 1, 1994
Effect of 1 alpha-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatmentJ Aerssens, R Van Audekercke, M Talalaj, et al.
Cancer Research|December 3, 1999
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivoP J Hjarnaa, E Jonsson, S Latini, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1992
Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivoG van der Pluijm, L Binderup, E Bramm, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|January 1, 1980
Basic antiinflammatory compounds. N,N',N''-Trisubstituted guanidinesS Rachlin, E Bramm, I Ahnfelt-Rønne, et al.
Agents and Actions|April 1, 1980
Macrophages from adjuvent arthritic rats preferentially synthetize prostacyclinI Ahnfelt-Rønne, L Binderup, E Bramm, et al.
Calcified Tissue International|February 1, 1991
Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisoloneP Geusens, J Dequeker, J Nijs, et al.
Endocrinology|April 1, 1996
Effect of 1alpha-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat modelJ Aerssens, R van Audekercke, M Talalaj, et al.
Breast Cancer Research and Treatment|September 25, 2003
Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumorsK W Colston, G Pirianov, E Bramm, et al.
Agents and Actions|December 1, 1977
Effect of calcitonin on different inflammatory modelsS E Abdullahi, E A Martelli, E Bramm, et al.
Agents and Actions|September 1, 1976
Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugsE Arrigoni-Martelli, E Bramm, E C Huskisson, et al.
Calcified Tissue International|December 1, 1994
Effect of 1 alpha-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatmentJ Aerssens, R Van Audekercke, M Talalaj, et al.
Cancer Research|December 3, 1999
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivoP J Hjarnaa, E Jonsson, S Latini, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1992
Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivoG van der Pluijm, L Binderup, E Bramm, et al.
Pageof 4